Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             20 results found
no title author magazine year volume issue page(s) type
1 ADMA and hyperhomocysteinemia Dayal, Sanjana
2005
vmr-5 1_suppl p. S27-S33
article
2 ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study Böger, Rainer H
2005
vmr-5 1_suppl p. S97-S102
article
3 ADMA: an emerging cardiovascular risk factor Böger, Rainer H
2005
vmr-5 1_suppl p. S1-S2
article
4 ADMA: its role in vascular disease Cooke, John P
2005
vmr-5 1_suppl p. S11-S17
article
5 ADMA metabolism and clearance Teerlink, Tom
2005
vmr-5 1_suppl p. S73-S81
article
6 Angiogenesis/vasculogenesis 2006
vmr-5 1_suppl p. S1-S17
article
7 Arginine metabolism in vascular biology and disease Morris, Sidney M
2005
vmr-5 1_suppl p. S83-S87
article
8 Asymmetric dimethylarginine (ADMA) accelerates cell senescence Bode-Böger, Stefanie M
2005
vmr-5 1_suppl p. S65-S71
article
9 Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials Böger, Rainer H
2005
vmr-5 1_suppl p. S19-S25
article
10 Atherothrombosis - the neurologist’s point of view Leys, Didier
2001
vmr-5 1_suppl p. 17-19
article
11 DDAH gene and cardiovascular risk Valkonen, Veli-Pekka
2005
vmr-5 1_suppl p. S45-S48
article
12 Endogenous production of nitric oxide synthase inhibitors Anthony, Shelagh
2005
vmr-5 1_suppl p. S3-S9
article
13 Foreword Belch, Jill
2001
vmr-5 1_suppl p. 1
article
14 Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA Sydow, Karsten
2005
vmr-5 1_suppl p. S35-S43
article
15 PAD awareness, risk, and treatment: new resources for survival - the USA PARTNERS program Hirsch, Alan T
2001
vmr-5 1_suppl p. 9-12
article
16 Peripheral arterial disease - epidemiological aspects Criqui, Michael H
2001
vmr-5 1_suppl p. 3-7
article
17 Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA) Maas, Renke
2005
vmr-5 1_suppl p. S49-S57
article
18 Quantification of ADMA: analytical approaches Schwedhelm, Edzard
2005
vmr-5 1_suppl p. S89-S95
article
19 Rationale for the use of platelet aggregation inhibitors in PAD patients Agnelli, Giancarlo
2001
vmr-5 1_suppl p. 13-15
article
20 Spotlight on endothelial progenitor cell inhibitors: short review Thum, Thomas
2005
vmr-5 1_suppl p. S59-S64
article
                             20 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands